Single-Photon Emission Computed Tomography Market Profound Impact on the Market over 2027

Global single-photon emission computed tomography market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by the rise in prevalence of chronic disorders, growing disease awareness levels among the population, and development of cost-effective and advanced treatment options. According to the newly published report by Future Market Insights titled “Single-Photon Emission Computed Tomography Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027),” revenue from the global single-photon emission computed tomography market is expected to increase at a CAGR of 6.9% during the forecast period 2017–2027. This market is fragmented with very few major players operating globally. Companies in the global market are focussing on driving growth in mature markets so as to maximise growth prospects. This exclusive report on the global single-photon emission computed tomography market indicates that North America represents the most lucrative market for single-photon emission computed tomography, followed by Western Europe and APEJ.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5826 

Global Single-Photon Emission Computed Tomography Market: Factors Boosting Revenue Growth

• Rising global demand for effective diagnostic techniques
• Emerging applications of new radiopharmaceuticals
• Global increase in healthcare expenditure
• Availability of favourable reimbursements for brain imaging
• Increased scanning efficiency with rapid technological advancements
• Rise in the number of free standing imaging centres

Global Single-Photon Emission Computed Tomography Market: Factors Restricting Revenue Growth

Regulatory impositions by various regulatory authorities in different countries as well as the rules and regulations laid down by the U.S. Food and Drug Administration and European Commission could affect the global single-photon emission computed tomography market. Also, currency fluctuations and changing taxation policies are likely to have a significant impact on the revenue growth of the global single-photon emission computed tomography market over the forecast period.

Global Single-Photon Emission Computed Tomography Market: Forecast by End User

On the basis of end user, the global market for single-photon emission computed tomography is segmented into hospitals, diagnostic imaging centres and ambulatory surgical centres. Although hospitals dominated the global SPECT market in 2016 with a valuation of US$ 898.7 Mn, diagnostic imaging centres are expected to witness significant growth during the forecast period 2017 – 2027, primarily due to the adoption of single-photon emission computed tomography devices in diagnostic imaging centres.

Global Single-Photon Emission Computed Tomography Market: Forecast by Product Type

By product type the market is segmented into single imaging gamma cameras and SPECT/CT. The single imaging gamma cameras segment dominated the global SPECT market in 2016 and is projected to continue to do so throughout the forecast period. However, SPECT/CT is the fastest growing segment in the global market, expanding at a CAGR of 9.3% during the forecast period.

Global Single-Photon Emission Computed Tomography Market: Forecast by Application

By application the global market for single-photon emission computed tomography is segmented into cardiology, oncology, neurology, and others. Neurology is the fastest growing segment by application type, expanding at a CAGR of 7.9% followed by oncology and cardiology.

Global Single-Photon Emission Computed Tomography Market: Forecast by Region

The North America single-photon emission computed tomography market accounted for the largest revenue share in 2016. Asia Pacific excluding Japan is expected to experience the highest growth rate of 8.9% between 2017 and 2027, primarily due to rising incidences of chronic disorders and a rapid growth in the ageing population.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5826 

Global Single-Photon Emission Computed Tomography Market: Key Players

GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD., PNPMed, NuCare Inc. are some of the key market players profiled in this report.

Phototherapy Lamps Market Expecting Worldwide Growth by 2026

Increasing adoption of phototherapy as a safer option for treatment of skin disorders has propelled the sales of phototherapy lamps across the globe. According to a recent research report by Future Market Insights, the global phototherapy lamps market is anticipated to expand robustly at a CAGR of 6.8% during the forecast period. The report projects that by the end of 2026, more than US$ 4.1 Bn worth of phototherapy lamps will be sold across the globe.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/phototherapy-lamps-market#tbl-content 

Regional insights from the report reveal that North America will dominate the global phototherapy lamps market in terms of revenues throughout the forecast period. The healthcare marketplace in the US and Canada has shown considerable rise in adoption of phototherapy as a safer treatment option for skin disorders. Consumer lifestyles in North America will continue to propel the incidence of common skin diseases, which will be mostly treated by the use of phototherapy lamps. In addition, robust infrastructure for adoption of phototherapy lamps has also supported the dominance of North America in the global market. The report reveals that in 2017, phototherapy lamps sold in the US and Canada will bring in nearly US$ 700 Mn in revenues.

LED-based phototherapy lamps to register highest sales

The study reveals that LED-based phototherapy lamps are the top-selling products in the global market. Low risk of burns, cost-effective production, and easy installation will continue to drive the demand for LED-based phototherapy lamps in the foreseeable future. By the end of 2026, nearly US$ 1.6 Bn worth of revenues procured in the global phototherapy lamps market will be accounted by the LED segment. The study also reveals that the demand for UV-based phototherapy lamps will be impressive, while halogen lamps will lose traction towards the end of the forecast period.

Skin care clinics to emerge as the largest end-user of phototherapy lamps

The report further reveals that hospitals will initially witness high traction in terms of end-users, but skin care clinics are projected to record the highest revenue share in the global market. By the end of 2026, phototherapy lamps used in skin care clinics is expected to bring in more than US$ 1.6 Bn revenues.

Growing effectiveness of phototherapy in psoriasis treatment to drive the sales of phototherapy lamps

On the basis of their applications, phototherapy lamps will be predominantly used in the treatment of psoriasis. In 2017, phototherapy lamps sold for treatment of psoriasis across the globe are expected to bring in over half a billion dollars. Over the forecast period, the applications of phototherapy lamps in treatment of neonatal jaundice are likely to register fastest CAGR of 8.1%.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5834 

Leading manufacturers of phototherapy lamps have been profiled in the report. Koninklijke Philips N.V., General Electric Company, Drägerwerk AG & Co. KGaA, Bistos Co. Ltd., TSE SPOL. S. R. O., The Daavlin Company, Fanem Ltda., Herbert Waldmann GmbH & Co. KG, Natus Medical Incorporated, and Schulze & Bohm GmbH are expected to actively partake in the expansion of the global phototherapy lamps market through 2026.

Cranial Stabilisation Devices Market Value Projected to Expand by 2027

Future Market Insights has published a new report titled “Cranial Stabilisation Devices Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027)” that studies the overall performance of the global cranial stabilisation devices market for an assessment period of 10 years. The global cranial stabilisation devices market is anticipated to expand at a significant CAGR over the forecast period. Technological advancements in the field of neuroscience across the globe is a favourable factor boosting revenue growth of the global cranial stabilisation devices market. Revenue from the global cranial stabilisation devices market is expected to reach US$ 472.9 Mn by 2017 end and is projected to reach US$ 792.8 Mn by the end of 2027. Sales revenue is anticipated to register a robust CAGR of 5.3% between 2017 and 2027.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2537

Global Cranial Stabilisation Devices Market: Key Trends

• Steady growth in neurosurgical procedures across the globe
• Increasing consolidations among key market players
• Rising preference for branded products
• Increasing awareness regarding regulatory concerns
• Rapidly expanding healthcare facilities across the globe
• Increasing spending on healthcare facilities across the world

Cranial Stabilization Devices Market: Macro Economic Factors

Over the last few years, government authorities in the Asia Pacific and the Middle East and Africa regions are encouraging start-up companies as well as MNCs to boost industrial growth in the healthcare and medical devices industry. Leading players in the medical devices market are capitalising on economies of scale to strengthen their position in the market. This is likely to have a positive impact on the global cranial stabilisation devices market.

Increasing incidence of life-threatening diseases due to changing lifestyles of people is creating a rise in demand for neurology procedures worldwide. It is expected that direct and indirect costs of treatment of neurological diseases and disorders will increase over a period of time. This is another factor likely to impact revenue growth of the global cranial stabilisation devices market.

Global Cranial Stabilisation Devices Market: Segmental Forecast

On the basis of product type, the global market for cranial stabilisation devices is segmented into Horseshoe Headrest, Skull Clamp System, and Brain Retractor System. Brain retractor system segment dominated the global cranial stabilisation devices market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Brain retractor system segment is expected to be the most lucrative among all product types, with an attractiveness index of 1.6.

By end use the market is segmented into hospitals, ambulatory surgical centres and specialised centres. Specialized centres segment is expected to be the second largest market for cranial stabilisation devices, with a market share index of 0.7. Ambulatory surgical centres segment remains the third largest market with a market share index of 0.5.

Global Cranial Stabilisation Devices Market: Forecast by Region

Key geographies tracked in this report include North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA. The APEJ cranial stabilisation devices market revenue is expected to expand at a significant CAGR over the forecast period. APEJ remains the third largest market due to increasing demand for cranial stabilisation devices such as horseshoe headrests, skull clamp systems and brain retractor systems. North America dominated the global cranial stabilisation devices market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. The North America cranial stabilisation devices market is expected to be the most lucrative among all regional markets, with an attractiveness index of 2.8.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2537

Global Cranial Stabilisation Devices Market: Key Players

Micromar Ind. Com. Ltda, Pro Med Instruments, Inc., Integra LifeSciences Corporation, and Changzhou Huida Medical Equipment Co. Ltd. are some of the top companies operating in the global cranial stabilisation devices market.

Coagulation Analysers Market to Reach a Valuation of US$ 1,514 Mn By 2027

A new report published by Future Market Insights titled ‘Coagulation Analysers Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027)’ studies the performance of the global coagulation analysers market over a 10 year assessment period from 2017 to 2027. The report presents the value forecast of the global coagulation analysers market and provides useful insights into the factors driving market growth as well as the factors restricting market growth. The estimates point to a revenue growth from US$ 756 Mn in the year 2017 to US$ 1,514 Mn by 2027 end, resulting in a CAGR of 7.2% during the period of assessment.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5843

Growing Prevalence of Cardiovascular Diseases and an Increase in the Number of Cancer Patients Fuelling Revenue Growth of the Coagulation Analysers Market

Cardiovascular diseases are one of the leading causes of deaths in the world and are considered as a global disease burden. As per the data provided by WHO, 17.5 million people across the world die from cardiovascular diseases every year, which accounts for 31 percent of all the deaths globally. In light of this, coagulation tests such as PT/INR are commonly used blood tests to identify the risk of cardiovascular diseases. An increasing prevalence of cardiovascular diseases is expected to boost the global market for coagulation analysers during the forecast period.

Research has indicated that malignancy affects the haemostatic system and vice versa. An imbalance of the haemostatic system in cancer patients raises their chances of developing thrombosis, haemorrhage or both. In addition, the haemostatic factor plays an important role in tumour progression and haemostatic components and cancer biology are interconnected in various ways. As per the American Cancer Society, in the year 2016, nearly 1,685,210 new cancer cases were registered in the U.S. This increase in the number of cancer patients is expected to drive the global coagulation testing market during the assessment period.

Global Coagulation Analysers Market: Segmentation and Forecast

The report segments the global coagulation analysers market on the basis of product type and end user. On the basis of product type, coagulation analysers are categorised as standalone analysers, table top analysers and portable analysers. On the basis of end use, the coagulation analysers market is segmented into hospitals, clinical laboratories and others.

• The table top analysers segment by product type is estimated to be valued at US$ 208 Mn in the year 2017, and is projected to reach a valuation of US$ 432 Mn by the end of the year 2027, exhibiting a CAGR of 7.6% during the period of assessment.
• By end use, the hospitals segment is estimated to be valued at US$ 244 Mn in the year 2017, and is projected to reach a valuation of US$ 450 Mn by the end of the year 2027, registering a CAGR of 6.3% during the period of assessment.

Global Coagulation Analysers Market: Regional Forecast

Future Market Insights tracks the performance of the global coagulation analysers market across the key geographies of North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. As per the forecast of Future Market Insights, the North America coagulation analysers market is estimated to be valued at US$ 286 Mn in the year 2017 and is projected to reach a value of US$ 546 Mn by the year 2027, exhibiting a CAGR of 6.7% during the period of assessment. The Western Europe coagulation analysers market is estimated to be valued at US$ 147 Mn in the year 2017 and is projected to reach a value of US$ 314 Mn by the year 2027, exhibiting a CAGR of 7.8% during the period of assessment.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5843

Global Coagulation Analysers Market: Vendor Insights

This report includes some of the important players operating in the global coagulation analysers market such as Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Helena Laboratories Corporation, Thermo Fisher Scientific Inc., Rayto Life and Analytical Sciences Co., Ltd., Nihon Kohden Corporation Siemens AG, Beckman Coulter Inc. (Danaher Corporation), Sysmex Corporation, Abbott Laboratories and Siemens AG. Manufacturers are concentrating on developing advanced analysers at a lower price, with an objective to witness an increase in their market share.

Renal Function Test Market Projected to Reach US$ 900 Mn by 2026

According to Future Market Insights (FMI), the global renal function test market is projected to register a steady expansion over the forecast period, 2017 to 2026. Revenues from worldwide use of renal function test are estimated to surpass US$ 900 Mn by 2026-end.

Public & Private Healthcare Organizations are Supporting Management of CKD through Programs & Initiatives

Increasing incidences of renal failure, and chronic kidney diseases (CKD) are considered to be the primary factors responsible for the significant demand for renal function tests. Unhealthy dietary habits, lack of physical exercise owing to hectic lifestyles, and stress, are commonly observed risk factors for diabetes, coronary heart diseases, hypercholesterolemia, and hypertension. These factors further lead toward dysfunctions in the kidney, which in turn creates demand for renal function tests. Surging number of people with diabetes who are highly susceptible to CKD are expected to propel the demand for renal function tests in the upcoming years. The resultant high sample volume is creating demand for highly effective and efficient renal function testing devices.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5845

Awareness about diagnostic benefits related to renal function tests is increasing among people. The advent of technologically advanced products associated with renal function tests such as automated analyzers has resulted into refinement of present point-of-care real-time testing capabilities. In addition, the private as well as public healthcare organizations are consistently striving to support the diagnosis and management of chronic kidney diseases through various programs and initiatives, thereby creating awareness and demand for renal function tests.

Key Takeaways from FMI’s Report on Renal Function Test Market

• North America will continue to be dominant in the global renal function test market, in terms of revenues. Between renal function test market in Europe and Asia-Pacific excluding Japan (APEJ), the former will account for a larger revenue share and the latter will register a relatively higher CAGR through 2026. The renal function test markets in Middle East & Africa (MEA) and Japan are projected to account for the lowest revenue share of the market throughout the forecast period.
• On the basis of product type, dipsticks are expected to be the leading contributor to the market growth, in terms of revenues. Revenues from sales of disposables and reagents are projected to register a relatively faster expansion, and will collectively account for over two-fifth share of the market during the forecast period.
• Hospitals are anticipated to remain the most lucrative end-users in the global renal function test market, with sales estimated to surpass US$ 450 Mn in revenues by 2026-end. Diagnostic laboratories are expected to remain the fast-expanding end-users of renal function tests through 2026. Revenues from renal function tests in diagnostic laboratories are projected to account for nearly one-third share of the market by 2026-end. Research institutes will continue to be the least lucrative end-users of renal function tests.
• In terms of test type, urine protein and microalbumin renal function test are together projected to account for over three-fifth revenue share of the market during the forecast period. Revenues from microalbumin renal function test will register the highest CAGR in the market through 2026. In addition, revenues from urine protein and serum creatinine renal function test are projected to increase at nearly equal CAGRs through 2026.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5845

Vendors in the global renal function test market are focusing on technological advancements through clinical trials. The intensive competitive landscape of the market is resulting into increasing mergers & acquisition activities, wherein smaller firms are acquired by well-established international vendors. Key player profiled by FMI’s report include Randox Laboratories, Elektronika, Acon Laboratories, Urit Medical, Nova Biomedical, Sysmex, Abbott, Roche, Beckman Coulter, and Siemens.

Automated CPR Devices Market is estimated to be worth US$ 191.2 Mn by 2027

Future Market Insights (FMI) announces the release of its latest outlook titled,“Automated CPR Devices Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017–2027)”. According to the report, the global automated CPR devices market was valued at US$ 60.0 Mn in 2016 and is anticipated to reach US$ 191.2 Mn by 2027, registering a compound annual growth rate (CAGR) of 11.3% throughout the 10 year forecast period.

Market Drivers and Restraints

The global automated CPR devices market is largely driven by a growing demand from emergency medical services and a rising need for technologically advanced EMS. An increasing public awareness of cardiac arrest and increasing training programmes is also positively influencing revenue growth of the automated CPR devices market. Also, increasing government funding and grants encouraging the use of automated CPR devices in order to improve survival rates of cardiac arrest victims coupled with a rapidly increasing geriatric population across the globe owing to the impact of reducing mortality rates and declining fertility rates has also widened the scope for automated CPR device manufacturers.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5343 

Conversely, high cost of automated CPR devices, the substantial weight of the device and high training requirements are some minor restraints in the global automated CPR devices market. Additionally, conflicting results from observational studies regarding the use of automated CPR devices is also hampering the growth of the automated CPR devices market. While some observational studies have confirmed that the application of automated CPR devices can immediately improve hemodynamic effect and perfusion, some studies show less or no impact from the use of such devices.

Unmet clinical needs are expected to offer favourable growth opportunities in the near future. Increasing demand for innovative products so as to ensure cardiac arrest survival rates through cardiopulmonary resuscitation are providing favourable prospects for growth of the global automated CPR devices market. There is a strong need for the improvement of existing CPR devices with some desired features such as inbuilt pulse rate check function and automated injectable function.

Global Automated CPR Devices Market: Forecast by End User

Among the various end users of automated CPR devices, the hospitals segment is likely to dominate throughout the forecast period with a CAGR of 11.6% in terms of value.The emergency medical services segment remains the third largest market and represents a Market Share Index of 0.6 over the forecast period.

Global Automated CPR Devices Market: Forecast by Region

Region-wise, Europe dominated the global automated CPR devices market in 2016 in terms of revenue, accounting for 36.5% revenue share. However, Asia Pacific is foreseen to witness a relatively high CAGR of 11.1%. The market in Europe is expected to remain dominant throughout the forecast period.

Adoption rates for automated CPR devices vary according to region, which is resulting in disparity in market trends across regions. Factors such as differentiation in EMS and its functioning and lack of awareness amongst the populace are responsible for the varying adoption rates across different geographies. The U.S. is witnessing major investments in automated CPR devices due to the increasing number of market players with new technologies in the region.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-5343 

Global Automated CPR Devices Market: Competitive Landscape

Key players considered in the global automated CPR devices market include ZOLL Medical Corporation, Physio-Control Inc., Brunswick Biomedical Technologies, Michigan Instruments, and SunLife Science Inc. The global automated CPR devices market is consolidated with the top two players bagging over 50% of the total market share. Most players are engaged in various activities such as new product development, increasing investments in clinical research, expansion of geographical presence and brand building via strong marketing strategies in order to sustain in the competitive global market.

Clinical Alarm Management Market is Expected to Generate Huge Profits by 2027

Clinical alarm management solutions are adopted by hospitals and ambulatory surgical centres to manage and respond to clinical alarms as and when they arise to minimize alarm fatigue. Clinical alarm management solutions are implemented by several enterprises for a number of applications and include clinical decision support tools, mobility solutions, central monitoring systems, alarm auditing software, and clinical alarm reporting software. In its recent report titled, ‘Clinical Alarm Management Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)’, Future Market Insights has conducted a thorough analysis of the global clinical alarm management market. The clinical alarm management market is anticipated to push past a value of US$ 4 billion by end 2027.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1713 

Component – Solutions Component Dominate Clinical Alarm Management Market

The solutions component is projected to be more than thrice the size of the services component at the end of the forecast period and key stakeholders in the clinical alarm management market are advised to take this into account. The solutions component could exceed a value of US$ 3 billion by the end of the decadal study with a third of this being in the clinical decision support tools sub-segment. However, a substantially higher CAGR is likely in the mobility solutions segment as the number of smartphone users has risen exponentially in the past few years. Most healthcare professionals access their smartphone to monitor their patients on a real-time basis via patient monitoring apps. This enhances caregiver efficiency by minimizing institutional operational cost and allows organizations to use mobility for alarm management as well as clinical decision support.

End User – Focus on Hospitals and Ambulatory Surgical Centres in Clinical Alarm Management Market

Hospitals and ambulatory surgical centres are the largest end-users in the clinical alarm management market and should remain so for the foreseeable future. Although hospitals are approx. thrice the size of ambulatory surgical centres, the latter is on track to post a higher CAGR of 9.5% from 2017 to 2027, making the segment vital for companies involved in the clinical alarm management market. A major challenge faced by hospitals is alarm fatigue that can occur because different clinical alarms generated by medical devices can have a devastating impact on clinicians, patients, and relatives. Alarm fatigue occurs when clinicians are desensitized and non-reactive on account of an overwhelming load and is a grave threat for patient safety. Human factors, staffing issues, and technological also come into play here and all this can significantly hamper growth of the clinical alarm management market.

Region – North America Largest Contributor in Clinical Alarm Management Market

North America had a market share of slightly under half the clinical alarm management market at the end of 2017 but is projected to lose a massive 420 BPS going forward. Nonetheless, its commanding lead ensures that Western Europe doesn’t surpass it during the course of the forecast period. The US accounts for roughly 4/5th of the North America clinical alarm management market because the US Department of Health and Human Services allow reimbursement models such as bundled payments. Medicare and Medicaid service centres are striving to achieve greater cancer care consistency and cost predictability with the adoption of clinical decision tools. These tools play a game-changing role improving safety, quality, and efficiency as they offer timely, relevant information to healthcare professionals at a lower cost.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1713  

Competition Dashboard in Clinical Alarm Management Market

Companies profiled in the clinical alarm management market report are Medtronic, GE Healthcare, Baxter, Koninklijke Philips, Connexall, Vocera, Drager, Mindray Medical International Limited, , and Spok Inc.

Takeaways

Vendors dealing in clinical alarm management software could try to streamline their product portfolio by seamlessly integrating their platform / solutions with local players through a joint venture or strategic partnership. Mobility solution is poised to witness immense growth as smartphone ownership will skyrocket in future. Therefore, investing in mobility solutions could be a wise bet.

Pneumonia Diagnostics Market Progresses for Huge Profits During 2017-2027

The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report titled ‘Pneumonia Diagnostics Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’, Future Market Insights has undertaken a comprehensive study of the pneumonia diagnostics market that is poised to be worth more than US$ 685 million in 2027.

Product Type – Focus on Streptococcus-based and Viral Pneumonia-based Product Types

The streptococcus-based product type is the largest in the pneumonia diagnostics market at the end of 2016 and is unlikely to fall behind anytime soon. The streptococcus-based segment is the only one worth more than US$ 100 million in 2017 alone. Streptococcus-based pneumonia is considered an invasive form of the infection with an incidence of 10 to 100 cases per a population of 100,000.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2970 

The viral pneumonia- based segment is predicted to witness the highest CAGR in the pneumonia diagnostics market over the course of the decade. The viral pneumonia segment of the pneumonia diagnostics market should cross US$ 180 million by end 2027, making it well worth the while of major stakeholders. Viral-based pneumonia is thought to cause approx. 8% of all cases of community-acquired pneumonia in the cases where patients required hospitalization.

Region – North America and Western Europe Vital in Pneumonia Diagnostics Market

North America has the maximum share in the pneumonia diagnostics market and is on track to retain this share for some time. The US, primarily due to its world-class healthcare infrastructure and a geriatric population susceptible to pneumonia, represents a larger opportunity than Canada in the North America pneumonia diagnostics market. In addition to this, there is high awareness about pneumonia and its debilitating effects on both infants and the elderly. The North America pneumonia diagnostics market is expected to just push past US$ 200 million by the end of the forecast period.

Western Europe follows North America in the pneumonia diagnostics market with Germany and the UK comprising the bulk of the regional market. The two behemoths represent more than 40% of the Western Europe pneumonia diagnostics market between themselves and companies are advised to focus their attention there. The Western Europe pneumonia diagnostics market is anticipated to record a robust CAGR of 6.2% from 2017 to 2027, making it a region too lucrative to ignore in the global pneumonia diagnostics market. The market attractiveness of Germany is much higher than that of the UK at 1.6.

Competition Dashboard in the Pneumonia Diagnostics Market

Prominent companies profiled in the pneumonia diagnostics market report include Thermo Fisher Scientific, Alere, Quidel Corporation, Becton Dickinson and Company, Meridian Bioscience, Qiagen N.V., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., and Beckman Coulter Inc.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-2970 

Takeaways

Changing global demographics coupled with greater medical awareness increase the potential for companies in the pneumonia diagnostics market. Manufacturers are seeking to introduce rapid diagnostics to exploit untapped opportunities and producers of pneumonia diagnostics have expanded the value chain to forward integrate the market in emerging economies. A high return on investment could be realized by shifting manufacturing from traditional culture techniques to rapid diagnostics at the point of care.

Hyaluronic Acid Products Market Size Projected to Rise Lucratively during 2027

The World Bank estimates that the geriatric population in the world’s most populous country China had reached 10% of the population in 2016. The United Nations believes that nearly a third of the country will be over the age of 60 in 2050. A geriatric population is far more susceptible to osteoporosis the treatment of which necessitates hyaluronic acid products. Future Market Insights in its report titled ‘Hyaluronic Acid Products Market: Global Industry Analysis 2012 –2016 and Opportunity Assessment 2017 – 2027’ anticipates the global hyaluronic acid products market to be worth approx. US$ 5 billion in 2027.

Product Type – Three Cycle Injection Products Critical in Hyaluronic Acid Products Market

The three-cycle injection product segment is the largest in the hyaluronic acid products market at the end of 2017 and is on track to retain its pole position for the next decade. The three cycle injection product segment is predicted to have a value of just under US$ 2 billion by end 2027, making it vital for key stakeholders in the hyaluronic acid products market. The market attractiveness of three cycle injection products is 1.2. However, three cycle injection products typically have a premium price and it remains to be seen if they become as popular in emerging economies as they are in developed ones.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-486 

Application – Osteoarthritis and Dermal Fillers Neck and Neck in Hyaluronic Acid Products Market

There is a close battle between the osteoarthritis and dermal fillers application segment in the hyaluronic acid products market with the former inching slightly ahead. The CAGR of the osteoarthritis segment is 7.8% to the 7.7% witnessed in the dermal fillers segment from 2017 to 2027. Therefore, it wouldn’t be advisable to ignore one of these over the other in the hyaluronic acid products market. There has been a noticeable spike in osteoarthritis patients seeking out alternative options to knee replacement in order to avoid the side effects of corticosteroids injections that could pose a challenge to growth in the hyaluronic acid products market.

Region – Target North America and Western Europe Hyaluronic Acid Products Market

North America and Western Europe hold the maximum share in hyaluronic acid products market and are likely to remain so for some time to come. The two regions are expected to be the only ones in the hyaluronic acid products market worth more than one billion dollars by the end of the forecast period with a higher CAGR in North America. Favourable reimbursement policies for treating various scar conditions fuels demand for hyaluronic acid products in the US. Furthermore, reimbursement for HA injections also play a major role.

Competition Dashboard in the Hyaluronic Acid Products Market

Future Market Insights has profiled a few of the companies in the hyaluronic acid products market. The companies are Allergan plc, Anika Therapeutics, Shanghai Jingfeng Pharmaceutical Co., Ferring Pharmaceuticals, Galderma SA, Sanofi, Salix Pharmaceuticals Ltd., Smith & Nephew, Zimmer Biomet, Seikagaku Corporation, and Fidia Farmaceutici.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-486 

Takeaways

Manufacturers in the hyaluronic acid products market have focused their attention on developing new custom-made implants for minimally invasive surgery. Companies now outsource their manufacturing to reduce the high cost and thereby improve their competitive position vis-à-vis their immediate rivals in hyaluronic acid products market. Lastly, companies have entered into collaboration activities to expand their portfolio and boost their presence across countries in hyaluronic acid products market.

Protein Expression Technology Market to Expand with Significant CAGR During 2017-2027

Protein expression alludes to the technique in which proteins are incorporated, adjusted and managed in living organisms. The innovation associated with the procedure incorporates utilization of expression vectors, reagents and competent cells. A research report by Future Market Insights gives an in-depth analysis of the various protein expression technologies in its new publication titled “Protein Expression Technology Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. It includes the market forecast for the revenue share and CAGR during the projected period i.e. 2017 to 2027.

According to this extensive research, the global protein expression market is expected to grow at a robust CAGR of 7.7% and reach a market size of more than US$ 3 Bn by the end of 2027 from a value of around US$ 1,700 Mn in 2017. The estimates are based on a systematic primary and secondary research, considering the major drivers, restraints that are limiting the market and also the trends following the global protein expression technology market.

To Learn More about This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1540 

Global Protein Expression Technology Market: Dynamics

The growth of global protein technology market is contributed mostly by the advancements in technology. It is also accompanied by many other factors that are helping in the expansion of market. The major drivers are enhanced sales network and distribution channels, increasing demand in proteomics and biologics and growing demand for therapeutic antibody research. However, there are also a few factors that are limiting the growth of global protein expression technology market like in-house development of expression systems, high cost associated with expression vectors and other reagents, complex workflow and also low protein production which has the maximum restraining force.

Global Protein Expression Technology Market: Segmental Highlights

The global protein expression technology market is segmented on the basis of expression system, product type, application, end user and region.

• Among these major segment types, expression system segment is expected to have the maximum impact on the market with mammalian expression system being the most dominant segment which marks a revenue of over US$ 630 Mn and is anticipated to reach a value of around US$ 1.6 Bn by the end of 2027
• The region segment is dominated by North America region in terms of value, with a CAGR of 8.5% throughout the period of forecast. The protein expression technology market in APEJ region is projected to grow at the highest pace to register a CAGR of 8.7% and reaching a revenue of about US$ 600 Mn by 2027 end
• The product type segment is dominated by Reagents, growing at a CAGR of over 8% during the forecast period. It is followed by expression vectors which is anticipated to reach a CAGR of over 7% during 2017-2027
• End user segment is another important segment type which includes pharmaceutical companies as its dominant segment. This segment is expected to mark a revenue value of US$ 710 Mn in 2017
• By application, protein therapeutics segment is expected to be highly lucrative. It is the leading segment in terms of both value share and growth rate. By the end of the forecast period, this segment is estimated to reach a value of more than US$ 1.5 Bn with a high 8.4% CAGR during the forecast period

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1540 

Global Protein Expression Technology Market: Competitive Landscape

This comprehensive research report has included profiles of major players involved in protein synthesis technologies. Major companies such as Lonza AG, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, QIAGEN N.V., Takara Bio, Inc., Fujifilm Diosynth Biotechnologies USA, Genscript Biotech Corporation, Promega Corporation, Hudson Robotics, Inc., New England Biolabs, Inc., Merck Millipore, GeneCopoeia, Inc., Bioneer Corporation and Oxford Expression Technologies Ltd.